EKSPLOITASI AI VOICE CLONING DALAM PEMASARAN DIGITAL: ANALISIS KEBOHONGAN DAN MANIPULASI SUARA DALAM IKLAN
Jurnal Imagine · 25.11.2024 · 4 (2) · 77-83
DOI: 10.35886/s0tsmn81 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Imagine, online erschienen am 25.11.2024. Verfasst von Asep Koswara. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
This research explores the dangers of using AI Voice Cloning in digital marketing, focusing on the context of gambling, which is prohibited in Indonesia. By analyzing advertisements from the social media account promoting the slot brand @fufuslot, the study employs a non-participant observational method to investigate how the voices of public figures, such as Rhoma Irama and Koh Denis Lim, are leveraged to capture consumer or gamer’s attention. The analysis results indicate that within ten days of the advertisement's launch, it successfully garnered 40,000 likes, 10,000 comments, and 133 shares, reaching millions of views. However, the effectiveness of this technology raises ethical and legal issues concerning voice manipulation in marketing, especially in the gambling context. The findings underscore the need for stricter regulations on misleading marketing practices to protect consumers from the negative influences of AI technology in modern marketing strategies.
Zitieren
APA
Koswara, A. (2024). EKSPLOITASI AI VOICE CLONING DALAM PEMASARAN DIGITAL: ANALISIS KEBOHONGAN DAN MANIPULASI SUARA DALAM IKLAN. Jurnal Imagine, 4(2), 77-83. https://doi.org/10.35886/s0tsmn81
Vancouver
Koswara A. EKSPLOITASI AI VOICE CLONING DALAM PEMASARAN DIGITAL: ANALISIS KEBOHONGAN DAN MANIPULASI SUARA DALAM IKLAN. Jurnal Imagine. 2024;4(2):77-83. doi:10.35886/s0tsmn81
BibTeX
@article{Koswara2024,
author = {Koswara, Asep},
title = {EKSPLOITASI AI VOICE CLONING DALAM PEMASARAN DIGITAL: ANALISIS KEBOHONGAN DAN MANIPULASI SUARA DALAM IKLAN},
journal = {Jurnal Imagine},
year = {2024},
volume = {4},
number = {2},
pages = {77--83},
doi = {10.35886/s0tsmn81}
}
EUVIMED